Literature DB >> 32266309

Perianal Disease and Granulomas: Think Out of the Box….

Ana Reis-Melo1,2, Maria do Céu Espinheira1, Isabel Pinto-Pais1, Artur Bonito Vitor3, Jacinta Bustamante4, Eunice Trindade1.   

Abstract

BACKGROUND: Chronic granulomatous disease (CGD) is a primary immunodeficiency due to a malfunction of NADPH oxidase. It is characterized by recurrent and severe infections caused by catalase-positive microorganisms and autoinflammatory manifestations. Recently, there has been described an NCF4 gene variant that causes a deficiency of p40<sup>phox</sup>, a subunit of NADPH oxidase. Patients with this deficiency appear to have a less severe clinical form as compared to classic CGD. CASE: A 15-year-old girl with vulvar lichen planus since she was 2 years old and suspected Crohn's disease (CD) was first seen at our hospital. At the age of 12 years, she had been submitted to sacrococcygeal cyst exeresis, without cicatrization of the surgical wound and extension of the lesion to the perianal area. The diagnosis of CD was questioned, and the patient underwent an endoscopic and radiologic assessment, which was normal. A skin biopsy from the perianal area revealed a granuloma; thus, CD with isolated perianal disease was assumed. After several different treatments including antibiotics, infliximab, and adalimumab, the perianal lesion persisted, with no associated gastrointestinal symptoms. Therefore, the hypothesis of an immunodeficiency was considered. An immunologic and genetic study revealed reduced oxidative burst in the phorbol myristate acetate test, with diminished reactive oxygen species production and a homozygous mutation in the NCF4 gene. The adolescent started prophylactic trimethoprim-sulfamethoxazole and became asymptomatic.
CONCLUSIONS: The present case highlights that alternative diagnoses to CD must be considered in the presence of isolated perianal disease with granulomatous inflammation, especially when the disease is refractory to conventional CD therapy.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Chronic granulomatous diseases; Crohn's disease; NCF4 gene; p40phox deficiency

Year:  2019        PMID: 32266309      PMCID: PMC7113594          DOI: 10.1159/000502358

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  16 in total

1.  Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.

Authors:  Necil Kutukculer; Ayca Aykut; Neslihan E Karaca; Asude Durmaz; Guzide Aksu; Ferah Genel; Erhan Pariltay; Özgür Cogulu; Elif Azarsız
Journal:  Scand J Immunol       Date:  2019-01-23       Impact factor: 3.487

2.  Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.

Authors:  Eugenia Shmidt; David A Wetter; Sara B Ferguson; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2011-07-14       Impact factor: 11.527

Review 3.  Mimics of Inflammatory Bowel Disease.

Authors:  Raina Shivashankar; Gary R Lichtenstein
Journal:  Inflamm Bowel Dis       Date:  2018-10-12       Impact factor: 5.325

4.  Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.

Authors:  Iván Guerra; Alicia Algaba; José Lázaro Pérez-Calle; María Chaparro; Ignacio Marín-Jiménez; Raquel García-Castellanos; Yago González-Lama; Antonio López-Sanromán; Noemí Manceñido; Pilar Martínez-Montiel; Elvira Quintanilla; Carlos Taxonera; Mónica Villafruela; Alberto Romero-Maté; Pilar López-Serrano; Javier P Gisbert; Fernando Bermejo
Journal:  J Crohns Colitis       Date:  2011-11-13       Impact factor: 9.071

Review 5.  Chronic granulomatous disease.

Authors:  Dirk Roos
Journal:  Br Med Bull       Date:  2016-03-16       Impact factor: 4.291

6.  Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications.

Authors:  Eduardo Tarazona-Santos; Moara Machado; Wagner C S Magalhães; Renee Chen; Fernanda Lyon; Laurie Burdett; Andrew Crenshaw; Cristina Fabbri; Latife Pereira; Laelia Pinto; Rodrigo A F Redondo; Ben Sestanovich; Meredith Yeager; Stephen J Chanock
Journal:  Mol Biol Evol       Date:  2013-07-02       Impact factor: 16.240

7.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Authors:  Juan D Matute; Andres A Arias; Nicola A M Wright; Iwona Wrobel; Christopher C M Waterhouse; Xing Jun Li; Christophe C Marchal; Natalie D Stull; David B Lewis; MacGregor Steele; James D Kellner; Weiming Yu; Samy O Meroueh; William M Nauseef; Mary C Dinauer
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

8.  Subclinical intestinal inflammation in chronic granulomatous disease patients.

Authors:  Arnon Broides; Orli Sagi; Vered Pinsk; Jacov Levy; Baruch Yerushalmi
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

9.  Course and treatment of perianal disease in children newly diagnosed with Crohn's disease.

Authors:  David J Keljo; James Markowitz; Christine Langton; Trudy Lerer; Athos Bousvaros; Ryan Carvalho; Wallace Crandall; Jonathan Evans; Anne Griffiths; Marsha Kay; Subra Kugathasan; Neal LeLeiko; David Mack; Petar Mamula; M Susan Moyer; Maria Oliva-Hemker; Anthony Otley; Marian Pfefferkorn; Joel Rosh; Jeffrey S Hyams
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

Review 10.  Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease.

Authors:  N L Rider; M B Jameson; C B Creech
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.